Abstract:Background: Acute non-variceal bleeding accounts for approximately 20% of all-cause bleeding episodes in patients with liver cirrhosis. It is associated with high morbidity and mortality therefore prompt diagnosis and endoscopic management are crucial. Aim: To evaluate available data on the efficacy of endoscopic treatment modalities used to control acute non-variceal gastrointestinal bleeding (GIB) in cirrhotic patients as well as to assess treatment outcomes. Methods: Employing PRISMA methodology, the MEDLINE was searched through PubMed using appropriate MeSH terms. Data are reported in a summative manner and separately for each major non-variceal cause of bleeding. Results: Overall, 23 studies were identified with a total of 1288 cirrhotic patients of whom 958/1288 underwent endoscopic therapy for acute non-variceal GIB. Peptic ulcer bleeding was the most common cause of acute non-variceal bleeding, followed by portal hypertensive gastropathy, gastric antral vascular ectasia, Mallory-Weiss syndrome, Dieaulafoy lesions, portal hypertensive colopathy, and hemorrhoids. Failure to control bleeding from all-causes of non-variceal GIB accounted for less than 3.5% of cirrhotic patients. Rebleeding (range 2%-25%) and mortality (range 3%-40%) rates varied, presumably due to study heterogeneity. Rebleeding was usually managed endoscopically and salvage therapy using arterial embolisation or surgery was undertaken in very few cases. Mortality was usually associated with liver function deterioration and other organ failure or infections rather than uncontrolled bleeding. Endoscopic treatment-related complications were extremely rare. Lower acute non-variceal bleeding was examined in two studies (197/1288 patients) achieving initial hemostasis in all patients using argon plasma coagulation for portal hypertensive colopathy and endoscopic band ligation or sclerotherapy for bleeding hemorrhoids (rebleeding range 10%-13%). Data on the efficacy of endoscopic therapy of cirrhotic patients vs non-cirrhotic controls with acute GIB are very scarce. Conclusion: Endotherapy seems to be efficient as a means to control non-variceal hemorrhage in cirrhosis, although published data are very limited, particularly those comparing cirrhotics with non-cirrhotics and those regarding acute bleeding from the lower gastrointestinal tract. Rebleeding and mortality rates appear to be relatively high, although firm conclusions may not be drawn due to study heterogeneity. Hopefully this review may stimulate further research on this subject and help clinicians administer optimal endoscopic therapy for cirrhotic patients.

Should Vasoconstrictors Be Considered in a Cirrhotic Patient with Acute Non-variceal Upper Gastrointestinal Bleeding?

Surgical therapy procedure in cirrhosis with portal hypertension

Early-TIPS Versus Current Standard Therapy for Acute Variceal Bleeding in Cirrhosis Patients: A Systemic Review With Meta-analysis

Woman With Hematochezia

Efficacy and safety of variceal embolization for primary prophylaxis in cirrhosis patients with challenges in standard treatments: preliminary results

Experience in the Treatment of Gastroesophageal Variceal Bleeding Caused by Portal Hypertension in Cirrhosis by Restricted Rehydration Combined with Gastroscopy

Characteristics of peptic ulcer bleeding in cirrhotic patients with esophageal and gastric varices

Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis.

Case report: Rapid development of acute symptomatic portal vein system thrombosis after endoscopic variceal therapy in a patient with liver cirrhosis

Predicting the risk of variceal rehemorrhage in cirrhotic patients with portal vein thrombosis: A two-center retrospective study

Medical management of variceal hemorrhage

Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis

Characteristics of peptic ulcer bleeding in cirrhosis with esophageal and gastric varices

Pharmacological therapy for the treatment of esophageal varices

The Effect Of Acute Variceal Bleeding Interventions On Reducing The Requirement Of Blood Transfusions In Cirrhotic Patients: A Systematic Review

Two Surgical Procedures for Esophagogastric Variceal Bleeding in Patients with Portal Hypertension

Risk Factors Associated with Failure of Endoscopic Combined Treatment to Prevent Varices Rebleeding in Patients with Liver Cirrhosis

Esophageal and Gastric Variceal Bleeding in Liver Cirrhosis: Embolization or Shunt

Treatment strategy for liver cirrhosis patients with portal hypertension.

Endoscopic management and outcome of non-variceal bleeding in patients with liver cirrhosis: A systematic review

Transjugular Intrahepatic Portosystemic Shunt May Be Superior to Conservative Therapy for Variceal Rebleeding in Cirrhotic Patients with Non-Tumoral Portal Vein Thrombosis: a Hypothesis.